U.S. Markets open in 5 hrs 2 mins
  • S&P Futures

    -3.50 (-0.11%)
  • Dow Futures

    -12.00 (-0.04%)
  • Nasdaq Futures

    -20.25 (-0.19%)
  • Russell 2000 Futures

    +0.50 (+0.03%)
  • Crude Oil

    +0.06 (+0.15%)
  • Gold

    -2.40 (-0.13%)
  • Silver

    +0.11 (+0.47%)

    -0.0007 (-0.0583%)
  • 10-Yr Bond

    0.0000 (0.00%)
  • Vix

    +0.22 (+0.77%)

    +0.0023 (+0.1840%)

    -75.11 (-0.70%)
  • CMC Crypto 200

    +17.23 (+8.24%)
  • FTSE 100

    -7.13 (-0.12%)
  • Nikkei 225

    +116.80 (+0.51%)

S&P 500 in Ugly Reversal as Tech Wreck Dashes Path to Record High

By Yasin Ebrahim

Investing.com –  The S&P 500 ended Tuesday in the red as a wave of selling hit stocks late in the day on reports that fiscal talks on the next coronavirus stimulus package had reached a stalemate. 

The Dow Jones Industrial Average fell 0.37%, or 103 points. The S&P 500 fell 0.79%, while the Nasdaq Composite fell 1.69%.

In an interview with Fox News, Senate Majority Leader Mitch McConnell confirmed that talks between the Democrats and the White House were at "a stalemate," souring investor optimism that lawmakers will agree on a new round of fiscal stimulus sooner rather than later.

Industrials pared gains on the news, as investors reined in bets on travel stocks, with the airlines, in particular, losing wind.

American Airlines (NASDAQ:AAL), United Airlines (NASDAQ:UAL) gave up gains to turn negative, while  Delta Air Lines (NYSE:DAL) ended up 1%.

Boeing (NYSE:BA) closed up just 0.4%, after shrugging off earlier data showing that the pace of order cancellations last month outweighed the pace of new orders its customers continue to pull orders for its much-maligned 737 MAX jets.

Tech's move deeper into the red also exacerbated the downside in the broader market, paced by a decline in the so-called fab 5 companies.

Facebook (NASDAQ:FB), Alphabet (NASDAQ:GOOGL), Apple (NASDAQ:AAPL), Amazon.com (NASDAQ:AMZN) and Microsoft (NASDAQ:MSFT), which account for about 25% of S&P 500, all fell.

On the vaccine front, Russia became the first country to approve a Covid-19 vaccine, which President Vladimir Putin said had already been given to his daughter.

But while many health professionals have raised questions over the safety and efficacy of the Russian-dubbed "Sputnik-V" vaccine, which went into clinical trials less than two months ago on June 17, the news helped lift investor optimism that an inoculation could be found sooner rather than later.

Financials held onto some gains, thanks to a jump in banks following a move higher in bond yields.

JPMorgan (NYSE:JPM) was up 3.2%, while Goldman Sachs (NYSE:GS) rose 0.8% and Bank of America (NYSE:BAC) was up more than 1%.

Higher interest rates are seen as a boon for banks, boosting net interest margin – the difference between the interest income generated by banks and the amount of interest paid out to their depositors.

In earnings news, Novavax (NASDAQ:NVAX), which is in the midst of developing a potential coronavirus vaccine, fell 16% as the company's announcement that three contracts for its potential coronavirus treatment were not exclusive offset better-than-expected quarterly results.

Canada Goose (NYSE:GOOS) fell 5% after the retailer's gloomy guidance offset quarterly results that were not as bad as feared.

Related Articles

Tesla launches five-for-one stock split

Kodak expects sales volumes to rebound after COVID-19 hit

Explainer: How the U.S. could block WeChat and TikTok from Americans